In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...